全文获取类型
收费全文 | 4265篇 |
免费 | 351篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 180篇 |
妇产科学 | 74篇 |
基础医学 | 416篇 |
口腔科学 | 38篇 |
临床医学 | 475篇 |
内科学 | 557篇 |
皮肤病学 | 57篇 |
神经病学 | 322篇 |
特种医学 | 173篇 |
外科学 | 530篇 |
综合类 | 35篇 |
一般理论 | 1篇 |
预防医学 | 439篇 |
眼科学 | 846篇 |
药学 | 150篇 |
肿瘤学 | 309篇 |
出版年
2023年 | 44篇 |
2022年 | 64篇 |
2021年 | 135篇 |
2020年 | 78篇 |
2019年 | 108篇 |
2018年 | 115篇 |
2017年 | 96篇 |
2016年 | 85篇 |
2015年 | 93篇 |
2014年 | 114篇 |
2013年 | 174篇 |
2012年 | 250篇 |
2011年 | 278篇 |
2010年 | 113篇 |
2009年 | 121篇 |
2008年 | 177篇 |
2007年 | 203篇 |
2006年 | 192篇 |
2005年 | 209篇 |
2004年 | 188篇 |
2003年 | 161篇 |
2002年 | 142篇 |
2001年 | 118篇 |
2000年 | 122篇 |
1999年 | 73篇 |
1998年 | 32篇 |
1996年 | 29篇 |
1994年 | 21篇 |
1993年 | 23篇 |
1992年 | 75篇 |
1991年 | 71篇 |
1990年 | 56篇 |
1989年 | 60篇 |
1988年 | 53篇 |
1987年 | 66篇 |
1986年 | 54篇 |
1985年 | 67篇 |
1984年 | 53篇 |
1983年 | 30篇 |
1982年 | 30篇 |
1981年 | 22篇 |
1980年 | 27篇 |
1979年 | 41篇 |
1978年 | 34篇 |
1977年 | 29篇 |
1976年 | 21篇 |
1975年 | 23篇 |
1974年 | 24篇 |
1968年 | 22篇 |
1966年 | 20篇 |
排序方式: 共有4621条查询结果,搜索用时 46 毫秒
981.
982.
983.
984.
Marissa Blieden Betts Sandra Milev Meredith Hoog Hyosung Jung Dušan Milenković Yi Qian Ming-Hui Tai Lucie Kutikova Guillermo Villa Christine Edwards 《Value in health》2019,22(2):210-219
Objectives
To identify risk equations for cardiovascular diseases (CVDs) in primary and secondary prevention settings that are used or recommended by health technology assessment (HTA) organizations and in clinical guidelines (CGs).Methods
A targeted literature review was conducted using a two-stage search strategy. First, HTA reviews of manufacturers’ drug submissions, reports from established HTA organizations (Europe, Canada, and Australia), and CGs from countries with and without HTA organizations, including the United States, were identified. Documents published between September 30, 2006 and September 30, 2016, were examined for cardiovascular risk equations, recommendations, and commentaries. Next, publications associated with risk equations and cited by HTA and CG documents were retrieved. This literature was examined to extract commentaries and risk equation study characteristics.Results
The review identified 47 risk equations, 25 in the primary CVD prevention setting (i.e., patients with no CVD history), including 5 for CVD prevention in diabetes and 22 solely in secondary prevention settings; 11 were identified for heart failure, 3 for stroke or transient ischemic attack, 2 for stable angina, and 11 for acute coronary syndrome or related conditions. A small set of primary prevention equations was found to be commonly used by HTAs, whereas secondary prevention equations were less common in HTA documents. CGs provided more risk equations as options than HTA documents.Conclusions
Although there is an abundance of risk equations developed for primary and secondary prevention, there remains a need for additional research to provide sufficient clinical and HTA guidance for risk estimation, particularly in high-risk or secondary prevention settings. 相似文献985.
Marissa K. Srour MD Ying Qu PhD Nan Deng PhD Kjirsten Carlson MD James Mirocha MS Bowen Gao MS Farnaz Dadmanesh MD Xiaojiang Cui PhD Armando E. Giuliano MD 《The breast journal》2021,27(5):432-440
The aim of this study is to characterize and compare changes in gene expression patterns of paired axillary lymph node (ALN) metastases from estrogen receptor (ER)-positive and triple-negative (TNBC) primary breast cancer (PBC). Patients with stage 2-3 PBC with macrometastasis to an ALN were selected. Gene expression of 2567 cancer-associated genes was analyzed with the HTG EdgeSeq system coupled with the Illumina Next Generation Sequencing (NGS) platform. Changes in gene expression between ER/PR-positive, HER2-negative PBC, and their paired ALN metastases were compared with TNBC and their paired ALN metastases. Fourteen pairs of ER-positive and paired ALN metastasis were analyzed. Compared with the PBC, ALN metastasis had 673 significant differentially expressed genes, including 348 upregulated genes and 325 downregulated genes. Seventeen pairs of TNBC and paired ALN metastasis were analyzed. ALN metastasis had 257 significant differentially expressed genes, including 123 upregulated genes and 134 downregulated genes. When gene expression of the ALN for ER-positive PBC was compared to that of TNBC, 97 genes were upregulated in both, and 115 genes were similarly downregulated. Common upregulated genes were associated with cell death, necrosis, and homeostasis. Common downregulated genes were those of migration, degradation of extracellular matrix, and invasion. Although ER-positive PBC and TNBC have a distinct gene expression profiles and distinct changes from PBC to ALN metastases, a significant number of genes are similarly up- or downregulated. Understanding the role of these common genomic changes may provide clues to understanding the metastatic process itself. 相似文献
986.
987.
Objective Before undergoing sacral nerve stimulation (SNS) for faecal incontinence (FI), patients are investigated with morphologic, dynamic and electrophysiologic tests. The purpose of our study was to evaluate their value in the selection of patients who may benefit most from neuromodulation. Method If temporary stimulation resulted in a good objective response, a permanent neuromodulator was implanted. Patients were reviewed at 3 months and then at 6 monthly intervals. Asked by telephone, patient’s satisfaction was described as good, satisfactory or poor. Results Forty‐five consecutive patients (41 females, median age 59 years) with FI (Wexner 16.1 ± 2.9) underwent SNS. Temporary stimulation was successful in 32 (71)% patients. At a median follow‐up of 33 months, the neuromodulator remained in place in 25 (55%) patients, two do whom switched it off, leaving 23 (51%) with a functioning neuromodulator. There was no statistically significant difference between the characteristics (including manometry, ultrasound and electrophysiology) of patients undergoing implantation (n = 32) or not (n = 13) and those with or without a functioning stimulator (n = 23: n = 13). In the 23 patients with a functioning stimulator the result was good in 12, satisfactory in five and poor in six. There was no statistically significant difference in the patient characteristics between those with a good result (n = 12) and the remainder (n = 32). Conclusion The findings suggest that investigation for FI does not facilitate patient selection for SNS and cannot be used to predict outcome. 相似文献
988.
Yukiko Morimoto Shannon M. Conroy Ian S. Pagano Marissa Isaki Adrian A. Franke Frank J. Nordt 《Nutrition and cancer》2013,65(2):307-314
One of the hypothesized protective mechanisms of soy against breast cancer involves changes in estrogen metabolism to 2-hydroxy (OH) and 16α-OH estrogens. The current analysis examined the effect of soy foods on the 2:16α-OH E1 ratio among premenopausal women during a randomized, crossover intervention study; women were stratified by equol producer status, a characteristic thought to enhance the protective effects of soy isoflavones. The study consisted of a high-soy diet with 2 soy food servings/day and a low-soy diet with <3 servings of soy/wk for 6 mo each; estrogen metabolites were measured in 3 overnight urines (baseline and at the end of the low- and high-soy diet) using gas chromatography mass spectrometry for the 82 women who completed the study. Urinary isoflavonoids were assessed by liquid chromatography mass spectrometry. When applying mixed models, the 2:16α-OH E1 ratio increased (P = 0.05) because of a nonsignificant decrease in 16α-OH E1 (P = 0.21) at the end of the high-soy diet. Similar nonsignificant increases in the 2:16α-OH E1 ratio were observed in equol producers (P = 0.13) and nonproducers (P = 0.23). These findings suggest a beneficial influence of soy foods on estrogen metabolism regardless of equol producer status. 相似文献
989.
PAC99: 8768+z, 8780-y, 0130Mm 相似文献
990.
Jennifer L. Hughes Trevor Brown J. David Edgar Michael D. Shields 《Pediatric allergy and immunology》2010,21(8):1107-1113
Hughes JL, Brown T, Edgar JD, Shields MD. Peanut allergy and allergic airways inflammation.Pediatr Allergy Immunol 2010: 21: 1107–1113.© 2010 John Wiley & Sons A/S Asthma is a major risk cofactor for anaphylactic deaths in children with peanut allergy. Peanut allergy is generally thought to be a lifelong condition, but some children outgrow their coexistent asthma. It has recently been shown that children who have ‘outgrown’ their asthma symptoms may have ongoing eosinophilic airways inflammation. The need for regular inhaled corticosteroid treatment in peanut allergic children and adolescents who have outgrown their asthma is however unclear. The aims of our study were to look at fractional exhaled nitric oxide levels (FeNO), as a non‐invasive marker of eosinophilic airways inflammation, in peanut allergic children and assess whether children with outgrown asthma had elevated levels. Children with peanut allergy were recruited at two pediatric allergy clinics in Belfast, UK. Exhaled nitric oxide levels (FeNO) were measured using the Niox Mino in all children. Of the 101 peanut allergic children who consented for enrolment in the study, 94 were successfully able to use the NIOX Mino. Age range was 4–15 yr (median 10 yr); 61% were boys. Thirty (32%) had never wheezed, 37 (39%) had current treated asthma, 20 (21%) had at least 1 wheezing episode within the last year but were not taking any regular asthma medication (wheeze no treatment), and 7 (7%) had outgrown asthma. All children with outgrown asthma had elevated levels of FeNO (>35 ppb), and 75% of children defined as ‘wheeze no treatment’ had elevated FeNO levels (>35 ppb). Outgrown asthma and children defined as ‘wheeze no treatment’ had higher levels of FeNO than those with no history of wheeze or current treated asthma (p = 0.003). In children with peanut allergy, we found that those who had outgrown asthma had elevated FeNO levels in keeping with ongoing eosinophilic airways inflammation. 相似文献